Cite this article as: Kartamihardja AAP, Nakajima T, Kameo S, Koyama H, Tsushima Y. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model. Objective: To investigate the distribution and clearance of retained gadolinium (Gd) in various parts of the brain after intravenously administering a Gd-based contrast agent (GBCA) in normal and renal failure mouse models. Methods: Two different mouse models: normal (n 5 12) and renal failure (n 5 12) were used. Clinical GBCAs (Gd-DTPA-BMA, 5 mmol kg
21, or Gd-DOTA, 5 mmol kg 21 ) were intravenously administered five times per week for 4 weeks. Both groups were divided into two subgroups based on the time point for sample collection: 3 days (3d) and 45 days (45d) after the last injection. Normal saline (5 ml kg 21